⌘K

Login Start Free

Home/Filings/4/0001102624-13-000571

4//SEC Filing

Lewis Michael E 4

Accession 0001102624-13-000571

CIK 0001261734other

View on SEC.gov Company Profile

Filed

May 9, 8:00 PM ET

Accepted

May 10, 7:43 PM ET

Size

5.2 KB

Accession

0001102624-13-000571

Insider Transaction Report

Form 4

Period: 2013-05-08

AEOLUS PHARMACEUTICALS, INC.AOLS

Lewis Michael E

Director

Transactions

Award
Non-qualified Stock Option (right to buy)
2013-05-08+75,000→ 75,000 total
Exercise: $0.44From: 2013-05-08Exp: 2013-08-08→ Common Stock (75,000 underlying)

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AEOLUS PHARMACEUTICALS, INC.

CIK 0001261734

Entity typeother

Related Parties

1

filerCIK 0001297065

Filing Metadata

Form type: 4
Filed: May 9, 8:00 PM ET
Accepted: May 10, 7:43 PM ET
Size: 5.2 KB

View on SEC.gov